ID

30179

Description

8-Chloro-Adenosine in Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00714103

Lien

https://clinicaltrials.gov/show/NCT00714103

Mots-clés

Versions (1)
  1. 17/05/2018 17/05/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

17 mai 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Leukemia NCT00714103

Anglais

Eligibility Leukemia NCT00714103

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00714103
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients must have a diagnosis of chronic lymphocytic leukemia and must be previously treated with at least one prior treatment regimen, including a purine-analogue based treatment.
Description

Prior Therapy Quantity Chronic Lymphocytic Leukemia | Therapeutic procedure Based Purine analog

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0023434
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1705938
UMLS CUI [2,3]
C1268902
2. patients must be rai stage iii or iv or rai stage 0-ii and have one or more criteria for active disease as defined by the nci-working group as: a) weight loss of more than 10% in the last 6 months; b) fatigue; c) fever or night sweats without evidence of infection; d) progressive anemia or thrombocytopenia; e) progressive lymphocytosis with a lymphocyte doubling time </= 6 months; or f) marked hypogammaglobulinemia or paraproteinemia.
Description

Rai Staging System | Weight decreased Percentage Timespan | Fatigue | Fever | Night sweats | Communicable Disease Absent | Progressive anemia | Thrombocytopenia Progressive | Lymphocytosis Progressive | Lymphocyte Doubling Time

Type de données

boolean

Alias
UMLS CUI [1]
C1514715
UMLS CUI [2,1]
C1262477
UMLS CUI [2,2]
C0439165
UMLS CUI [2,3]
C0872291
UMLS CUI [3]
C0015672
UMLS CUI [4]
C0015967
UMLS CUI [5]
C0028081
UMLS CUI [6,1]
C0009450
UMLS CUI [6,2]
C0332197
UMLS CUI [7]
C0865245
UMLS CUI [8,1]
C0040034
UMLS CUI [8,2]
C0205329
UMLS CUI [9,1]
C0024282
UMLS CUI [9,2]
C0205329
UMLS CUI [10,1]
C0024264
UMLS CUI [10,2]
C2986483
3. all patients must have a zubrod performance status of </= 2.
Description

Zubrod Performance Status

Type de données

boolean

Alias
UMLS CUI [1]
C3714786
4. all patients must be age >/= 18 years.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
5. patients may not receive concurrent treatment for their cll and must have been off treatment (chemotherapy, immunotherapy, or radiotherapy) for 4 weeks prior to treatment on this study and recovered from toxic effects of that therapy.
Description

Absence Therapeutic procedure Chronic Lymphocytic Leukemia | Chemotherapy Absent | Immunotherapy Absent | Therapeutic radiology procedure Absent | Toxic effect Patient recovered

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0023434
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0021083
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C1522449
UMLS CUI [4,2]
C0332197
UMLS CUI [5,1]
C0600688
UMLS CUI [5,2]
C1115804
6. all patients must have adequate renal function indicated by serum creatinine </=2.5x upper limits of normal (uln) and adequate liver function indicated by alt or ast </= 2.5x uln and total bilirubin </= 2.5x uln.
Description

Renal function | Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
7. all patients must have a pre-treatment platelet count of >/= 50,000 /µl and not require transfusion to maintain this platelet count unless thrombocytopenia is due to marrow infiltrated with disease.
Description

Platelet Count measurement pre treatment | Absence Requirement Transfusion | Exception Thrombocytopenia | Etiology Marrow Infiltration Disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032181
UMLS CUI [1,2]
C2709094
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C1879316
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0040034
UMLS CUI [4,1]
C0015127
UMLS CUI [4,2]
C0376152
UMLS CUI [4,3]
C0332448
UMLS CUI [4,4]
C0012634
8. all patients or appropriate surrogate must provide informed consent.
Description

Informed Consent | Informed Consent Patient Representatives

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0030701
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients with active uncontrolled autoimmune hemolytic anemia or immune thrombocytopenia purpura.
Description

Autoimmune hemolytic anemia Uncontrolled | Immune thrombocytopenic purpura Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0002880
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0398650
UMLS CUI [2,2]
C0205318
2. patients with active uncontrolled fungal, bacterial, or viral infection.
Description

Mycoses Uncontrolled | Bacterial Infection Uncontrolled | Virus Disease Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0026946
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0004623
UMLS CUI [2,2]
C0205318
UMLS CUI [3,1]
C0042769
UMLS CUI [3,2]
C0205318
3. patients who are pregnant or breast-feeding.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Retour au début de la page

Similar models

Eligibility Leukemia NCT00714103

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00714103
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Prior Therapy Quantity Chronic Lymphocytic Leukemia | Therapeutic procedure Based Purine analog
Item
1. patients must have a diagnosis of chronic lymphocytic leukemia and must be previously treated with at least one prior treatment regimen, including a purine-analogue based treatment.
boolean
C1514463 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C0087111 (UMLS CUI [2,1])
C1705938 (UMLS CUI [2,2])
C1268902 (UMLS CUI [2,3])
Rai Staging System | Weight decreased Percentage Timespan | Fatigue | Fever | Night sweats | Communicable Disease Absent | Progressive anemia | Thrombocytopenia Progressive | Lymphocytosis Progressive | Lymphocyte Doubling Time
Item
2. patients must be rai stage iii or iv or rai stage 0-ii and have one or more criteria for active disease as defined by the nci-working group as: a) weight loss of more than 10% in the last 6 months; b) fatigue; c) fever or night sweats without evidence of infection; d) progressive anemia or thrombocytopenia; e) progressive lymphocytosis with a lymphocyte doubling time </= 6 months; or f) marked hypogammaglobulinemia or paraproteinemia.
boolean
C1514715 (UMLS CUI [1])
C1262477 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0872291 (UMLS CUI [2,3])
C0015672 (UMLS CUI [3])
C0015967 (UMLS CUI [4])
C0028081 (UMLS CUI [5])
C0009450 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
C0865245 (UMLS CUI [7])
C0040034 (UMLS CUI [8,1])
C0205329 (UMLS CUI [8,2])
C0024282 (UMLS CUI [9,1])
C0205329 (UMLS CUI [9,2])
C0024264 (UMLS CUI [10,1])
C2986483 (UMLS CUI [10,2])
Zubrod Performance Status
Item
3. all patients must have a zubrod performance status of </= 2.
boolean
C3714786 (UMLS CUI [1])
Age
Item
4. all patients must be age >/= 18 years.
boolean
C0001779 (UMLS CUI [1])
Absence Therapeutic procedure Chronic Lymphocytic Leukemia | Chemotherapy Absent | Immunotherapy Absent | Therapeutic radiology procedure Absent | Toxic effect Patient recovered
Item
5. patients may not receive concurrent treatment for their cll and must have been off treatment (chemotherapy, immunotherapy, or radiotherapy) for 4 weeks prior to treatment on this study and recovered from toxic effects of that therapy.
boolean
C0332197 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0021083 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C1522449 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0600688 (UMLS CUI [5,1])
C1115804 (UMLS CUI [5,2])
Renal function | Creatinine measurement, serum
Item
6. all patients must have adequate renal function indicated by serum creatinine </=2.5x upper limits of normal (uln) and adequate liver function indicated by alt or ast </= 2.5x uln and total bilirubin </= 2.5x uln.
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Platelet Count measurement pre treatment | Absence Requirement Transfusion | Exception Thrombocytopenia | Etiology Marrow Infiltration Disease
Item
7. all patients must have a pre-treatment platelet count of >/= 50,000 /µl and not require transfusion to maintain this platelet count unless thrombocytopenia is due to marrow infiltrated with disease.
boolean
C0032181 (UMLS CUI [1,1])
C2709094 (UMLS CUI [1,2])
C0332197 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C1879316 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0040034 (UMLS CUI [3,2])
C0015127 (UMLS CUI [4,1])
C0376152 (UMLS CUI [4,2])
C0332448 (UMLS CUI [4,3])
C0012634 (UMLS CUI [4,4])
Informed Consent | Informed Consent Patient Representatives
Item
8. all patients or appropriate surrogate must provide informed consent.
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Autoimmune hemolytic anemia Uncontrolled | Immune thrombocytopenic purpura Uncontrolled
Item
1. patients with active uncontrolled autoimmune hemolytic anemia or immune thrombocytopenia purpura.
boolean
C0002880 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0398650 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Mycoses Uncontrolled | Bacterial Infection Uncontrolled | Virus Disease Uncontrolled
Item
2. patients with active uncontrolled fungal, bacterial, or viral infection.
boolean
C0026946 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0004623 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0042769 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
3. patients who are pregnant or breast-feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial